Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Multiple Endocrine Neoplasia × fluorodopa F 18 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Glioma 3 Hypoglycemia 2 Glioblastoma 2 Parathyroid Neoplasms 1 Multiple Endocrine Neoplasia 1 Insulinoma 1 Infant, Newborn, Diseases 1 Hyperparathyroidism 1 Hyperinsulinism 1 Hypercalcemia 1 Glucose Metabolism Disorders 1

Interventions

pertuzumab 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 Leflunomide 1 Erlotinib Hydrochloride 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00001277 2022-06-07

Studies of Elevated Parathyroid Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

1,553 enrolled 8 charts

EndocrineHead & Neck

Hypercalcemia, Hyperparathyroidism, Hypoglycemia, Multiple Endocrine Neoplasia, Parathyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡